Specification BPC-157 TB-500 (Thymosin Beta-4) Cartalax (AED) Sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser Ala-Glu-Asp Molecular Formula C62H98N16O22 C212H350N56O78S C12H19N3O8 Molecular Weight 1419.5 g/mol 4963.4 g/mol 333.29 g/mol CAS Number 137525-51-0 77591-33-4 205640-90-0 PubChem CID 9941957 16132341 87815447 Synonyms Bepecin, Bpc 15, Body protection compound 15, Pentadecapeptide Thymosin Beta 4, Thymosin 4, TB500, Timbetasin T-31, AED, Alanyl-glutamyl-aspartic acid
Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes patients: the association between remaining -cell function and the achievement of the glycated hemoglobin target 1 year after initiation
Their AI doctor remembers your history and can help you navigate complex interactions safely
Who Should Discuss Compounded Semaglutide Carefully With Their Provider Certain medical histories require careful consideration before starting semaglutide: personal or family history of medullary thyroid cancer, acute pancreatitis, severe gallbladder disease, uncontrolled diabetes complications, or severe kidney disease
could not demonstrate any benefit of NAC treatment, compared with placebo, on lung function, quality of life, or inflammatory markers in patients with sarcoidosis-associated ILD (148)
